MAP2K7 and esophageal squamous cell carcinoma: To further investigate whether the activation of MEK/ERK/CREB pathway is involved in the EMT process of ESCC cells, we used PD98059 to inhibit the phosphorylation of MEK/ERK and then observed the subsequent changes of EMT proteins and cell migration and invasion ability.